MiRNAs are also promising biomarkers of PD with cognitive decline due to their critical roles in synaptic plasticity, memory, and the regulation of neurodegenerative disease-associated proteins such as α-syn, amyloid-β, and tau [41,42]. This evidence concerns the gene MAPT and Parkinson disease.